Hantavirus infection: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
(5 intermediate revisions by 4 users not shown) | |||
Line 3: | Line 3: | ||
'''For patient information, click [[Hantavirus infection (patient information)|here]]''' | '''For patient information, click [[Hantavirus infection (patient information)|here]]''' | ||
{{Hantavirus infection}} | {{Hantavirus infection}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{ADG}} {{USAMA}} {{SMP}} {{MMF}} | ||
{{SK}} Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS); Nephropathia epidemica (NE); Hemorrhagic fever with renal syndrome (HFRS) | {{SK}} Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS); Nephropathia epidemica (NE); Hemorrhagic fever with renal syndrome (HFRS) | ||
Line 10: | Line 10: | ||
== [[Hantavirus infection historical perspective|Historical Perspective]] == | == [[Hantavirus infection historical perspective|Historical Perspective]] == | ||
== [[Hantavirus infection classification|Classification]] == | |||
== [[Hantavirus infection pathophysiology|Pathophysiology]] == | == [[Hantavirus infection pathophysiology|Pathophysiology]] == | ||
Line 28: | Line 29: | ||
== Treatment == | == Treatment == | ||
[[Hantavirus infection medical therapy|Medical Therapy]] | [[Hantavirus infection primary prevention|Primary Prevention]] | [[Hantavirus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hantavirus infection future or investigational therapies|Future or Investigational Therapies]] | [[Hantavirus infection medical therapy|Medical Therapy]] | [[Hantavirus infection surgery|Surgery]] | [[Hantavirus infection primary prevention|Primary Prevention]] | [[Hantavirus infection secondary prevention|Secondary Prevention]] |[[Hantavirus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hantavirus infection future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Line 41: | Line 42: | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Nephrology]] | |||
[[Category:Cardiology]] | |||
[[Category:Pulmonology]] |
Latest revision as of 21:57, 29 July 2020
For patient information, click here
Hantavirus infection Microchapters |
Patient Information |
---|
Diagnosis |
Treatment |
Case Studies |
Hantavirus infection On the Web |
American Roentgen Ray Society Images of Hantavirus infection |
Directions to Hospitals Treating Hantavirus pulmonary syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] Usama Talib, BSc, MD [3] Seyedmahdi Pahlavani, M.D. [4] Furqan M M. M.B.B.S[5]
Synonyms and keywords: Sin nombre virus infection; Hantavirus cardiopulmonary syndrome (HCPS); Nephropathia epidemica (NE); Hemorrhagic fever with renal syndrome (HFRS)
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Hantavirus pulmonary syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention |Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D. List of contributors: Pilar Almonacid